ACONW
Aclarion, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$0.03
−35.50%Price chart
Aug 4Aug 7Aug 12Aug 17Aug 20Aug 26Aug 31Sep 3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
1.8x
Market Cap
$15025.17
MomentumView details →
1D Return
−35.50%
YTD Return
−31.93%
RSI (14)
47.9
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
1.8x
Market Cap
$15025.17
RSI (14)
47.9
MomentumView details →
1D Return
−35.50%
YTD Return
−31.93%
Similar companies
Latest newsMore news →
Aclarion announced the University of Arizona College of Medicine – Phoenix as a new clinical site in its CLARITY trial, bringing the total to ten actively enrolling sites.16d agoAclarion, Inc. announced that the United States Patent and Trademark Office issued a Notice of Allowance for its patent application titled 'Multi-Voxel Prescription for Lumbar Disc Evaluation', extending its IP protection to over 65 issued and pending patents worldwide.24d agoAclarion announced that its Nociscan platform is now available at Goodman Campbell Brain & Spine at Ascension St. Vincent, the first site in Indiana to offer the technology.32d ago